Patients with type 2 diabetes, a disease estimated to affect more than 5.3 million Spaniards, have been struggling for months to find one of the most commonly prescribed drugs to treat the disease, which Affects 422 million people.
talk later ozampicOne of the GLP-1 analog drugs, which not only effectively improve blood sugar control, but also help with weight loss.
this medicine only It is given to patients who, apart from being diagnosed with diabetes, are also suffering from obesity (BMI between 25 and 29.9).
Why is Ozempic Expiring?
juan pedro risquezVice President of the General Council of Pharmaceutical Colleges, tells this newspaper that its inappropriate use is one of the main reasons that explains the paucity of pharmacies inside and outside our borders.
and it’s not some endocrinologist They are prescribing it to patients who have problems with excess weight, but not diabetes.
“The problems of supply continue, and not only in Spain, but also in neighboring countries”, highlights the president of the College of Pharmacists in Brazil.
“This is a drug that requires a prescription and is indicated for obese diabetics. Take it without a medical diagnosis and, of course, without a prescription, can put our health at risk,
Currently, the availability of this type of drug is “intermittent”. The Spanish Agency for Medicines and Health Products (Aemps) warns that, as appears in its prospectus, they are “authorized” to improve glycemic control in the treatment of adults with type 2 diabetes “by diet and exercise”. not controlled enough” …
Therefore, priority should be given to the use of these remedies “for authorized conditions”, which is none other than glycemic control in patients with diabetes.
Supply issue, suggests organization, expandable to other injectable drugs in pre-filled pens Trulicity why Bydureon,
Saxenda, the only obesity drug approved in Spain
in spain we have saxendaA drug that is given once daily and is indicated for people with a body mass index (BMI) over 30.
It should be injected into the abdomen, thigh or upper arm at any time of the day, regardless of meals.
other medicine, Wegobi, has not yet been authorized in our country, although it is alreadyapproved by Agency for Medicines in the United States (FDA) and consists of a single injection of semaglutide (type 2 diabetes medicine) that promotes the release of insulin to compensate for high blood sugar levels.
Sharp jump in demand for Ozampic in last quarter
The extreme demand for this type of drug, which has emerged in the last quarter of this year, has made the pharmaceutical industry “not enough”, although there are alternative treatments “they are also injectable” and have the same efficacy.
“We do not have exact data, but it seems that there has been an increase in the consumption of this drug (ozampic) because, in addition to the intended indication, the fact has also been added that some endocrinologists are treating obesity with this drug”.
In social networks, this drug has gained such popularity that is not typical for a medical device.
Celebrities such as Twitter CEO Elon Musk have shared the “secret” of their diet on their account: “Fasting, Ozempic and abstaining from delicious food.”
For this reason, after several celebrities shared on their social networks the pharmacist sends a clear message that they use this drug for a purpose other than the one for which it was approved.
“is required medical prescription, and no one is going to get this product without a prescription. And, moreover, it can cause changes in your health, because it is not convenient to take them on your own.
Ozempic: how much does it cost and how is this drug prescribed?
As you can read in their prospectus, ozampicFrom Novo Nordisk, the active substance is semaglutide, which helps to lower blood sugar levels in the body, only when the sugar level is too high. It also helps prevent heart disease.
It can only be used in patients with type 2 diabetes who are over 18 years of age, and when other medicines prescribed for this disease have not worked, together with a healthy and balanced diet and physical exercise.
This medicine makes a feeling full By mimicking the hormones that control appetite. And the results show that the reduction in body weight is 6% to 15% in one year.
The cost of the 1.5 ml pre-filled pen is 128.15 Euro. But since it is a drug funded by the national health system, the cost for patients is reduced to 4.24 euros.
The starting dose is 0.25 mg once a week for one month.
The dose is then increased by 0.5 mg a week, going up to 2 mg “if blood sugar is not adequately controlled.”
Side effects include nausea, vomiting or diarrhoea, which can lead to dehydration, severe and persistent pain in the abdominal area, experiencing an episode of low blood sugar (hypoglycemia) or worsening vision. Previously suffering from diabetic eye disease.
Sales skyrocket on the black market, which are usually counterfeit
Just one Simple search in a browser on the Internet To realize that, in recent months, there has been an increase in the illegal sale of drugs that require a prescription. Some drugs suffered not only because of supply problems, but also because of the impossibility of purchasing them without a prescription.
Despite protests from the labs, the internet has become a veritable black market for all kinds of treatments: from the worrying to the diazepam You orphaneduntil ozampic, It can cost more than 150 euros on the Internet.
The General Council of Pharmaceutical Colleges warns that “special care should be taken because in addition to the health problems that may occur if the drug is acquired without actually being needed, there is also the possibility that they are counterfeit.”
The illegal sale of drugs that “alter the health of citizens is irresponsible, in a system that is as guaranteed as that of Spanish pharmacies, and which is very dangerous.”
Medicines subject to medical prescription can only be acquired in pharmacies open to the public, which are legally authorized and which appear on a list published by the competent authority. Never via the Internet, as stated in Royal Decree 870/2013 of 8 November.